Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

With these key hires, Alpha Cognition is poised to advance its mission of improving the lives of patients and families ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

Early detection is critical, as it offers patients and their families more time to manage the disease and explore treatment options. Alzheimer’s: A Growing Concern Alzheimer’s disease is a ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

The search for answers to Alzheimer's disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of ...